|

Medical Release Print

AUTHORIZING Patient’s NAME (please print): Last: __________________ First ______________ M.I.___

     Date of Birth: ___________________ Social Security #: ______ – _____ – ______

AUTHORIZATION FOR RELEASE OF INFORMATION AND DISCUSSION BETWEEN

National Alliance of Methadone Advocates (NAMA)
435 Second Avenue
New York, NY 10010
tel/fax: 212 595-6262

AND

_____________________________________________  (Person/Facility)
______________________________________________   (Address)
______________________________________________   (Address)
______________________________________________  (City, ST, Zip)
(telephone)  ____________________   (fax)  ___________________

WE REQUEST ALL PERTINENT MEDICAL RECORDS FROM ATTENDING PHYSICIANS, HOSPITALS AND OTHER HEALTH CARE PROVIDERS. THE PURPOSE OF THIS RELEASE IS TO ALLOW WRITTEN AND/OR VERBAL COMMUNICATION PERTAINING TO MEDICAL INFORMATION INCLUDING BUT, NOT LIMITED TO: clinical and discharge summaries, other complaints, counselors notes, medical orders, the results of medical and psychiatric evaluations, case reports and psychological assessments. THIS RELEASE ALSO AUTHORIZES COMMUNICATIONS in verbal or written form between NAMA and its representatives ______________________ and the above named person facility or facility representatives pursuant to the patient listed above. This authorization may be withdrawn in writing at any time and terminates on _______________________.**

ADDITIONAL INFORMATION REQUIRED: ________________________________________________
______________________________________________________________________________
______________________________________________________________________________

I understand that information specific to my medical history can be released with this consent. I can cancel this consent at any time but I understand the cancellation will not affect any information previously released under the agreement. I further understand that my notice of cancellation must be in writing.

I understand that information about my case is confidential and protected under the Federal regulations governing confidentiality of Alcohol and Drug Abuse Patient Records, 42CFR, Part 2 and 45 CFR, Parts 160 and 164 and cannot be disclosed without my written consent unless otherwise provided for in the regulations. I approve the release of this information. I understand what this agreement means and I am satisfied with my explanations which I may have requested and received.

________________________________

Signature of Patient
__________________________________
Signature of Witness
________________________________

Printed name
__________________________________
Printed name
________________________________

Date of Signature
__________________________________
Date of Signature

**  According to HIPPA the new patient privacy regulations a release must have a specific start time and end time which should not be more than one (1) year for compliancy.

© Copyright 2004 National Alliance of Methadone Advocates
wmethadone.org   Last Update: February 15, 2004

Similar Posts

  • Workshop Wednesday, October 10th

    Admin 11/25/2021

    Workshop Wednesday, October 10th Past Present and Future: A Selection of Unfinished Business in Methadone Treatment Moderator, Howard Lotsof, NAMA Acting Membership Director Gary Nessenbaum, Washington Advocates for Methadone Maintenance (President). The Patients’ Perspectives on the Changes in the Methadone Treatment System. Carmen Pearman, NAMA Regional Director and The MAG of Indiana (President). Tapering –…

  • National Methadone Conference 2001 Sponsored by American Methadone Treatment Association

    Admin 04/07/2023

    Attention: This presentation contains pictures and takes time to download.  Please be patient! Opioid Treatment in the 21st Century: Implementing the Vision St. Louis October 7-10, 2001 Five YEAR PLAN AVAILABLE IN POLICY MAKERS LUNCHEON SECTION   Advocacy Events and Patient Participation NAMA at AMTA Conference 2001 Sunday, October 7th Pre-conference Meeting 9 A.M. to…

  • How Methadone Works by Joycelyn Woods

    Admin 06/24/2021

    National Alliance of Methadone Advocates The Pharmacology of Methadone Ignorance about methadone abounds. Professionals working in the field receive very little or no training at all about the very medication that they will be administering. Rarely is addiction viewed as a disease and under the domain of the medical profession. Even the medical profession does…

  • |

    Methadone As Normal Medicine

    Admin 03/17/2023

    SUMMARY Methadone prescribing increased tenfold in the last four years in Belgium. This has been made possible through involvement of general practitioners in methadone treatment. Drug overdoses, crime and even presence of methadone on the black market have decreased at the same time. Introduction During the last four years, methadone consumption in Belgium increased tenfold…

  • Late Breaking News

    Admin 09/01/2021

    Best Practices: Treatment of Opiate Dependence Conference Update   Physician Training for Use of Buprenorphine   The conference planning committee working with the Center for Substance Abuse Treatment and the American Academy of Addictions Psychiatry will be offering the following 8-hour physician workshop during the Best Practices: Treatment of Opiate Dependence Conference, scheduled for March…

  • Blind Dosing

    Admin 05/05/2023

    Methadone maintenance treatment has been the most effective treatment for addiction to heroin resulting the cessation of heroin use and criminal behavior. Prior to the development of methadone maintenance treatment over 28 years ago narcotic addiction was considered incurable and a behavioral disorder under the control of law enforcement. Drs. Dole and Nyswander brought the…